New Revelations Question Trump-Era Approach to Deportation Case of Pro-Palestine Student
Attorneys representing Mahmoud Khalil, a former student at Columbia...
Revocation of Order of Canada Membership for Two Former Honourees
The Governor General of Canada, Mary Simon, has officially sanctioned the removal of two individuals...
In Brief Posted: 10:30 AM PDT · May 12, 2026 Image Credits: SpaceX (opens in a new window) Google and SpaceX are in talks to launch orbital data centers in space, reports The Wall Street Journal, citing sources familiar with the matter. The potential deal comes as SpaceX gears up for its $1.75 trillion IPO
The apparently insatiable demand for AI compute has data center entrepreneurs looking to the stars. There’s a key problem: There aren’t enough rockets to put data centers in orbit around Earth, and they’re too expensive. Most of the players are hoping that SpaceX’s Starship — expected to make its 12th test flight as soon as
The Trump administration on Friday launched a new website that will house a collection of “new, never-before-seen” files about UFOs, according to the Pentagon. (And yes, we’re apparently okay with calling them UFOs again, as the URL to the new website is war.gov/ufo.) In a public announcement by the Defense Department — which, under Trump
Companies working on batteries, semiconductors, and medical devices generate vast amounts of data — and much of it ends up scattered across spreadsheets and legacy systems, making it hard to use to improve products or understand failures. San Francisco-based startup Altara, which just secured $7 million in seed funding, says it has built an AI
In this photo illustration Hantavirus samples are seen in Ankara, Turkiye on May 6, 2026. Arman Onal | Anadolu | Getty Images The U.S. Centers for Disease Control and Prevention said there are no hantavirus cases in the country as of Thursday, as it monitors 41 people across the U.S. for the virus. The agency
A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen plans to advance an experimental drug for Alzheimer's disease to late-stage testing despite disappointing mid-stage trial data, the company said Thursday. Biogen said its experimental drug that targets tau, a protein associated with the memory-robbing disease, failed to show better responses at higher doses.
A cruise ship outbreak of hantavirus has rattled the public and reignited fears of another global health scare as passengers disperse across multiple countries, including the U.S. The World Health Organization reported 11 cases linked to the outbreak as of Tuesday, nine of which it confirmed, including three deaths. No Americans have tested positive as
We use cookies to measure marketing efforts and improve our services. Please review the cookie settings and confirm your choice.